The bill amends section 893.03 of the Florida Statutes to exclude cannabis and its derivatives from Schedule I of controlled substances for bona fide scientific research purposes. This new legal language permits the use of cannabis in research conducted under applicable federal, state, or institutional regulations, thereby facilitating scientific studies aimed at understanding the effects and benefits of cannabis. The amendment reflects a growing recognition of the need for scientific inquiry into cannabis while ensuring that regulatory oversight is maintained. The effective date of the bill will be established upon its passage, allowing researchers to begin utilizing cannabis in their studies promptly.

In addition to the cannabis provisions, the bill introduces new legal language to classify and regulate various synthetic cannabinoids, substituted phenethylamines, tryptamines, and phenylcyclohexylamines. It provides a comprehensive list of specific compounds and categorizes them into different classes, ensuring that any material containing these substances will be subject to regulation unless exempted or approved by the FDA. The bill emphasizes the importance of controlling these substances due to their potential for abuse and health risks, enhancing public safety and health regulations. The new regulations are set to take effect on October 1, 2025, allowing for necessary adjustments in enforcement and compliance.

Statutes affected:
S 728 Filed: 893.03